Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR6 | P51684 | 1/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.38 |
| ▸ | PPARG | P37231 | 1/20 | 0.32 |
| ▸ | CYP19A1 | P11511 | 5/20 | 0.32 |
| ▸ | MITF | O75030 | 1/20 | 0.31 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.31 |
| ▸ | ABHD16A | O95870 | 1/20 | 0.31 |
| ▸ | PRKCA | P17252 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6325466 | 1.00 | CCR6 (0.58) | CCR6CYP1A2PPARGCYP19A1MITF | |
| SCHEMBL6332038 | 0.94 | CCR6 (0.67) | CCR6CYP1A2PPARGCYP19A1ABHD16A | |
| SCHEMBL6325386 | 0.94 | CCR6 (0.62) | CCR6CYP1A2PPARGABHD16APRKCA | |
| SCHEMBL6325383 | 0.94 | CCR6 (0.62) | CCR6CYP1A2PPARGABHD16APRKCA | |
| SCHEMBL6325611 | 0.94 | CCR6 (0.67) | CCR6CYP1A2PPARGCYP19A1ABHD16A | |
| SCHEMBL6325610 | 0.94 | CCR6 (0.67) | CCR6CYP1A2PPARGCYP19A1ABHD16A | |
| SCHEMBL1532163 | 0.82 | CCR6 (0.46) | CCR6CYP1A2PPARGCYP19A1MITF | |
| SCHEMBL1532165 | 0.82 | CCR6 (0.46) | CCR6CYP1A2PPARGCYP19A1MITF | |
| SCHEMBL1532199 | 0.76 | CCR6 (0.41) | CCR6CYP1A2 | |
| SCHEMBL1532200 | 0.76 | CCR6 (0.41) | CCR6CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050009928-A1 | Cyclopentanone derivative | ZEON CORPORATION (JP) | 2005-01-13 | — | — | US | disclosed |
| EP-1420005-A1 | CYCLOPENTANONE DERIVATIVE | Zeon Corporation (JP) | 2004-05-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050009928-A1 | Cyclopentanone derivative | PTGIS, CYP51A1, TRPA1 | CCR6 777/4885CYP1A2 57/4885PPARG 1670/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.